Sodium-glucose cotransporter 2 inhibitors may reduce incidence of respiratory events in Type 2 diabetics
1. In this retrospective cohort study, patients with Type 2 Diabetes (T2D) using sodium-glucose cotransporter 2 inhibitors (SGLT2is) were found ...









